Results 61 to 70 of about 115,037 (313)
Impact of a Pharmacist-Provided Spirometry Service on Access to Results in a Primary Care Setting
Objectives: The primary objective of this study was to determine the effect of a pharmacist-provided spirometry service within a federally qualified health center on the percentage of spirometry referrals completed with results reviewed by the ordering ...
Lisa A. Mueller +3 more
doaj +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Objectives To explore the patient experience of a spirometry test used to confirm chronic obstructive pulmonary disease (COPD) diagnosis in patients with suspected smoking-related COPD.Design This is a qualitative study, performed with open interviews in
Laurent Plantier +4 more
doaj +1 more source
BackgroundVarious breathing exercises are used to enhance lung function. However, many patients have reported experiencing breathlessness and an increased work of breathing during their use, but evidence supporting this is limited.
Preeyaphorn Songsorn +6 more
doaj +1 more source
Pharmacist-Driven Spirometry Screening to Target High-Risk Patients in a Primary Care Setting
Objectives: The primary objective of this study is to determine the effect of proactive pharmacist identification of high-risk patients eligible for diagnostic spirometry testing on the percentage of appropriate spirometry referrals ordered and the ...
Jangus B. Whitner +2 more
doaj +1 more source
Spirometry as a Predictor of Cardiometabolic Disease [PDF]
Tianshi David Wu
openalex +1 more source
Telehealthcare for chronic obstructive pulmonary disease [PDF]
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a disease of irreversible airways obstruction in which patients often suffer exacerbations. Sometimes these exacerbations need hospital care: telehealthcare has the potential to reduce admission
Car, Josip +5 more
core +3 more sources
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta +5 more
wiley +1 more source
Race-specific spirometry equations may overestimate asthma control in Black children and adolescents
Background A growing body of evidence suggests that use of race terms in spirometry reference equations underestimates disease burden in Black populations, which may lead to disparities in pulmonary disease outcomes.
Allison J. Burbank +8 more
doaj +1 more source
Breathing SPACE – a practical approach to the breathless patient. [PDF]
Breathlessness is a common symptom which may have multiple causes in any one individual and causes which may change over time. Breathlessness campaigns encourage people to see their GP if they are unduly breathless.
Baxter, N, Hopkinson, NS
core +1 more source

